Negative magnetic resonance imaging (MRI) on active surveillance (AS) cannot justify avoiding scheduled biopsy as the risk of clinically significant disease is too great. AS protocols should involve prostate-specific antigen, MRI, and physical examination combined with scheduled repeat biopsy.
The evidence in the field of diagnosis, staging, and treatment of localised prostate cancer (PCa) is evolving rapidly. The 2024 European Association of Urology (EAU)-European…
Stereotactic body radiotherapy (SBRT) without androgen deprivation therapy (ADT) has lower rates of incontinence and sexual dysfunction, with a small trade-off in bowel bother, compared…
Stereotactic body radiotherapy (SBRT) without androgen deprivation therapy (ADT) has lower rates of incontinence and sexual dysfunction, with a small trade-off in bowel bother, compared…
In a contemporary cohort of previously untreated patients with metastatic renal cell carcinoma, 8.1% had brain metastases. We found that intensive systemic and focal therapies…
Patients with non–muscle-invasive bladder cancer (NMIBC) are at high risk of recurrence and progression. The rates for these events are impacted by clinical and pathological…
This overview of the 2024 European Association of Urology guidelines offers valuable insights into risk factors, diagnosis, classification, prognostic factors, treatment, and follow-up of non–muscle-invasive…
Emmett L, Subramaniam S, Crumbaker M, et al
Yu JB, DeStephano DM, Jeffers B, et al
Despite recent therapeutic advances, metastatic castration-resistant prostate cancer (mCRPC) portends a poor prognosis, with a median overall survival (OS) of <2 yr [1], highlighting the need…
Declining prostate-specific antigen levels during [177Lu]Lu-PSMA-617 treatment of prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer were strongly associated with prolonged radiographic progression-free survival, overall…
